Neurosurgical outcome in infants with low-grade glioma - systematic review
Authors: Dzionsko, H; Lindenmeyer, C; Horn, S; Grosser, J; Bruckner, T; Thole-Kliesch, T; Hernaiz Driever, P; Thomale, U-W; Fernandes Arroteia, I
Source journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2026-11-20)
DOI: 10.1007/s00381-026-07524-1
Abstract
INTRODUCTION: Low-grade gliomas (LGGs) in infants pose significant clinical challenges due to their biologically distinct behavior and frequent location in surgically complex regions. While resection remains the preferred initial treatment, its feasibility is frequently limited by age-specific clinical and tumor-related factors. This review explores the role of tumor resection in infants and its association with survival, disease progression, and neurological outcome. METHODS: A systematic literature search identified studies published within the last decade reporting surgical outcomes in infants with LGGs. Retrospective and prospective cohort studies and relevant case reports were included. Methodological quality was assessed, and relevant data were extracted and analyzed. RESULTS: Complete resection was less commonly achieved in infants (20.1% vs. 30.9% in total), who demonstrate higher rates of tumor progression and more frequently require multimodal treatment strategies. Resectability was influenced by tumor location, growth pattern, and patient age. Although infants appear to experience lower overall survival rates and greater need for adjuvant, non-surgical therapies, a greater extent of resection is consistently associated with improved survival outcomes, reduced rates of reoperation, and decreased reliance on additional therapeutic modalities. CONCLUSION: In infants with LGG, the maximal safe extent of resection should be pursued where anatomically feasible. However, particularly for midline tumors, where extensive resection is often not possible, comprehensive assessment of tumor biology and further investigation of non-surgical treatment options are essential to optimize therapeutic strategies.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.